Literature DB >> 20577745

[Familial exudative vitreoretinopathy].

D Finis1, J Stammen, A M Joussen.   

Abstract

Familial exudative vitreoretinopathy (FEVR) is an autosomal dominant inherited disease with a penetrance of nearly 100% and is mostly found in Asia. The most important sign is a temporal avascular retina with pathologically changed vessels combined with a temporal dragging of the disk and a heterotopy of the macula. In contrast to retinopathy of prematurity, only full-term children without oxygen therapy are affected. Clinical severity is highly variable. A stage of an asymptomatic gene carrier with peripheral ischemia only visible on angiography up to a massive deterioration of vision because of a combined tractional and rhegmatogenous retinal detachment is possible. All stages with intra- or subretinal exudates require therapy. First-line therapy is the coagulation of the leaky vessels to reduce the exudation. In addition cryocoagulation is possible. Advanced stages with complex retinal detachments usually require a vitrectomy to prevent further loss of visual function.

Entities:  

Mesh:

Year:  2010        PMID: 20577745     DOI: 10.1007/s00347-010-2201-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  17 in total

1.  [Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

Authors:  A Alsheikheh; W Lieb; F Grehn
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

2.  The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11.

Authors:  Y Li; C Fuhrmann; E Schwinger; A Gal; H Laqua
Journal:  Am J Ophthalmol       Date:  1992-06-15       Impact factor: 5.258

3.  Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

4.  Familial exudative vitreoretinopathy.

Authors:  V G Criswick; C L Schepens
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

5.  Familial exudative vitreoretinopathy. An expanded view.

Authors:  J Gow; G L Oliver
Journal:  Arch Ophthalmol       Date:  1971-08

6.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

7.  Familial exudative vitreoretinopathy. Results of surgical management.

Authors:  S D Pendergast; M T Trese
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

8.  [Eales' disease--10 years experience with a rare disease].

Authors:  B M Stoffelns; C Kramann; K Schoepfer
Journal:  Klin Monbl Augenheilkd       Date:  2009-04-21       Impact factor: 0.700

9.  Autosomal dominant exudative vitreoretinopathy.

Authors:  R R Ober; A C Bird; A M Hamilton; K Sehmi
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

10.  Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab.

Authors:  Mizuki Tagami; Sentaro Kusuhara; Shigeru Honda; Yasutomo Tsukahara; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-16       Impact factor: 3.117

View more
  2 in total

1.  [Rhegmatogenous retinal detachment : Epidemiology and risk factors].

Authors:  N E Bechrakis; A Dimmer
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

2.  Mutation spectrum in a cohort with familial exudative vitreoretinopathy.

Authors:  Ning Qu; Wei Li; Dong-Ming Han; Jia-Yu Gao; Zheng-Tao Yang; Li Jiang; Tian-Bin Liu; Yan-Xian Chen; Xiao-Sen Jiang; Liang Zhou; Ji-Hong Wu; Xin Huang
Journal:  Mol Genet Genomic Med       Date:  2022-07-25       Impact factor: 2.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.